Lipsky PE - Search Results

1

Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases.

Illei GG, Lipsky PE. Illei GG, et al. Among authors: lipsky pe. Curr Opin Immunol. 2000 Dec;12(6):712-8. doi: 10.1016/s0952-7915(00)00167-9. Curr Opin Immunol. 2000. PMID: 11102777 Review.

2

Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus.

Shirota Y, Yarboro C, Fischer R, Pham TH, Lipsky P, Illei GG. Shirota Y, et al. Ann Rheum Dis. 2013 Jan;72(1):118-28. doi: 10.1136/annrheumdis-2012-201310. Epub 2012 Aug 2. Ann Rheum Dis. 2013. PMID: 22858586 Clinical Trial.

3

Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.

Grammer AC, Slota R, Fischer R, Gur H, Girschick H, Yarboro C, Illei GG, Lipsky PE. Grammer AC, et al. Among authors: lipsky pe. J Clin Invest. 2003 Nov;112(10):1506-20. doi: 10.1172/JCI19301. J Clin Invest. 2003. PMID: 14617752 Free PMC article. Clinical Trial.

4

Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.

Illei GG, Tackey E, Lapteva L, Lipsky PE. Illei GG, et al. Among authors: lipsky pe. Arthritis Rheum. 2004 Jul;50(7):2048-65. doi: 10.1002/art.20345. Arthritis Rheum. 2004. PMID: 15248202 Free article. Review. No abstract available.

5

Biomarkers in systemic lupus erythematosus.

Illei GG, Lipsky PE. Illei GG, et al. Among authors: lipsky pe. Curr Rheumatol Rep. 2004 Oct;6(5):382-90. doi: 10.1007/s11926-004-0013-4. Curr Rheumatol Rep. 2004. PMID: 15355751 Review.

6

Identification and characterization of circulating human transitional B cells.

Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Sims GP, et al. Among authors: lipsky pe. Blood. 2005 Jun 1;105(11):4390-8. doi: 10.1182/blood-2004-11-4284. Epub 2005 Feb 8. Blood. 2005. PMID: 15701725 Free PMC article.

7

Abnormal differentiation of memory T cells in systemic lupus erythematosus.

Fritsch RD, Shen X, Illei GG, Yarboro CH, Prussin C, Hathcock KS, Hodes RJ, Lipsky PE. Fritsch RD, et al. Among authors: lipsky pe. Arthritis Rheum. 2006 Jul;54(7):2184-97. doi: 10.1002/art.21943. Arthritis Rheum. 2006. PMID: 16802356 Free article.

8

Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.

Valencia X, Yarboro C, Illei G, Lipsky PE. Valencia X, et al. Among authors: lipsky pe. J Immunol. 2007 Feb 15;178(4):2579-88. doi: 10.4049/jimmunol.178.4.2579. J Immunol. 2007. PMID: 17277168 Clinical Trial.

9

Rationale for interleukin-6 blockade in systemic lupus erythematosus.

Tackey E, Lipsky PE, Illei GG. Tackey E, et al. Among authors: lipsky pe. Lupus. 2004;13(5):339-43. doi: 10.1191/0961203304lu1023oa. Lupus. 2004. PMID: 15230289 Free PMC article. Review.

10

Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.

Goklemez S, Hasni S, Hakim FT, Muraro PA, Pirsl F, Rose J, Memon S, Fowler DF, Steinberg SM, Baker EH, Panch SR, Gress R, Illei GG, Lipsky PE, Pavletic SZ. Goklemez S, et al. Among authors: lipsky pe. Rheumatology (Oxford). 2022 Aug 3;61(8):3317-3328. doi: 10.1093/rheumatology/keab877. Rheumatology (Oxford). 2022. PMID: 34875023 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

717 results

Search Page